Koios Medical

By Koios Medical
· USA
Koios Medical — Thyroid and breast ultrasound reading, same underlying algorithm.
Diagnostic
Radiology
Production
FDA Cleared
Regulatory status
FDA Cleared
Deployment
Production
Clinical role
Adjunct (decision support)
Headquarters
USA
AI type
Diagnostic

Precise indication

Thyroid and breast ultrasound reading, same underlying algorithm.

Regulatory status

FDA cleared for both thyroid and breast indications.

Clinical evidence

Vendor-supported

Trade press coverage based on the vendor’s clearance announcement.

Independent

Not found in this research pass — verify before publishing.

Real-world deployment

Crowdfunded financing (Wefunder) round found, suggesting a comparatively modest scale versus other entries in this scan.

Interoperability

European status

Editorial verdict

Limits and uncertainties

Likely a smaller deployment scale than most other entries — confirm before presenting alongside larger-scale examples.

Sources

https://www.fiercebiotech.com/medtech/fda-clears-koios-medical-s-ultrasound-reading-ai-spots-breast-thyroid-cancer-two-seconds

This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate

At a glance
Vendor
Koios Medical
Headquarters
USA
AI type
Diagnostic
Specialty
Clinical role
Adjunct (decision support)
CE marking
Notified body
EU AI Act
Data hosting
Last verified
Reviewed by
How we evaluate

Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.

A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.

Read the methodology →

Spotted an error?

Vendors, authors and clinicians can request a correction. Corrections are dated on the profile.